SCHEMBL7083338

SCHEMBL7083338

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2cccc3ccccc23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
KAT6A Q92794 8/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 2/20 0.43
TP53 P04637 1/20 0.43
NPC1 O15118 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 1/20 0.41
FFAR1 O14842 1/20 0.41
AKR1B1 P15121 1/20 0.41
SPHK2 Q9NRA0 1/20 0.41
SPHK1 Q9NYA1 1/20 0.41
ABCB1 P08183 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078520 0.87 ALDH1A1 (0.53) MEN1KMT2ASMN1; SMN2POLBALDH1A1
SCHEMBL7076725 0.85 MTNR1B (0.48) MEN1KMT2ASMN1; SMN2TP53NPC1
SCHEMBL7080328 0.84 MEN1 (0.48) MEN1KMT2AKAT6ASMN1; SMN2TP53
SCHEMBL7077439 0.83 ALDH1A1 (0.44) MEN1KMT2AKAT6ASMN1; SMN2POLB
SCHEMBL7081565 0.83 USP2 (0.47) MEN1KMT2AKAT6ASMN1; SMN2POLB
SCHEMBL7080300 0.83 ALDH1A1 (0.48) MEN1KMT2AKAT6ASMN1; SMN2NPC1
SCHEMBL7083205 0.82 ALDH1A1 (0.52) MEN1KMT2AKAT6ASMN1; SMN2ALDH1A1
SCHEMBL7050498 0.81 SMPD1 (0.52) MEN1KMT2AKAT6ASMN1; SMN2ALDH1A1
SCHEMBL7080208 0.80 SMPD1 (0.53) MEN1KMT2AKAT6ASMN1; SMN2ALDH1A1
SCHEMBL7076746 0.80 SMPD1 (0.53) MEN1KMT2AKAT6ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN MEN1 4502/4885KMT2A 934/4885KAT6A 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.